These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1456401)
1. Biology of neuroblastomas in Japan found by screening. Hayashi Y; Hanada R; Yamamoto K Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):342-7. PubMed ID: 1456401 [TBL] [Abstract][Full Text] [Related]
3. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892 [TBL] [Abstract][Full Text] [Related]
4. Different karyotypic patterns in early and advanced stage neuroblastomas. Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218 [TBL] [Abstract][Full Text] [Related]
5. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification. Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726 [TBL] [Abstract][Full Text] [Related]
6. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152 [TBL] [Abstract][Full Text] [Related]
7. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line. Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033 [TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399 [TBL] [Abstract][Full Text] [Related]
9. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related]
10. Surgical aspects of N-myc oncogene amplification of neuroblastoma. Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178 [TBL] [Abstract][Full Text] [Related]
11. Mass screening of neuroblastoma in Sapporo City, Japan. Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398 [TBL] [Abstract][Full Text] [Related]
12. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery? Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341 [TBL] [Abstract][Full Text] [Related]
13. Biological aspects of neuroblastomas identified by mass screening in Quebec. Brodeur GM; Look AT; Shimada H; Hamilton VM; Maris JM; Hann HW; Leclerc JM; Bernstein M; Brisson LC; Brossard J; Lemieux B; Tuchman M; Woods WG Med Pediatr Oncol; 2001 Jan; 36(1):157-9. PubMed ID: 11464873 [TBL] [Abstract][Full Text] [Related]
14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma. Kubota M; Suita S; Tajiri T; Shono K; Fujii Y J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782 [TBL] [Abstract][Full Text] [Related]
16. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933 [TBL] [Abstract][Full Text] [Related]
17. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859 [TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project. Woods WG; Lemieux B; Tuchman M Pediatrics; 1992 Jan; 89(1):114-8. PubMed ID: 1727993 [TBL] [Abstract][Full Text] [Related]